Publication date: December 2026 Source: JAAD International, Volume 29 Author(s): Mathias Willaert, Sophie C. van Helmond, Lieke van Vugt, Antoni Gostyński, Tristan H. van Dongen, Sherief R. Janmohamed, Manon Zweers, Tamar E.C. Nijsten, DirkJan Hijnen, Rick Waalboer-Spuij
Baricitinib and ritlecitinib in alopecia areata: A nationwide prospective real-world registry study. // JAAD International. – URL: https://www.sciencedirect.com/science/article/pii/S266632872600177X?dgcid=rss_sd_all
Baricitinib and ritlecitinib in alopecia areata: A nationwide prospective real-world registry study. JAAD International. https://www.sciencedirect.com/science/article/pii/S266632872600177X?dgcid=rss_sd_all
“Baricitinib and ritlecitinib in alopecia areata: A nationwide prospective real-world registry study.” JAAD International.
@article{article50681,
title = {Baricitinib and ritlecitinib in alopecia areata: A nationwide prospective real-world registry study},
journal = {JAAD International},
url = {https://www.sciencedirect.com/science/article/pii/S266632872600177X?dgcid=rss_sd_all}
}